To be specific, NO pathways contribute to pathogenesis of neurodegeneration in AD and other neurodegenerative dementias by involving in neuroinflammation, while SPSB1 negatively control NO production and limit cellular toxicity [38]. Here, SPSB1 is linked to Alzheimer disease.